Nclexpn Quiz: Laboratory And Diagnostic Monitoring

What this quiz covers

This quiz focuses on Laboratory And Diagnostic Monitoring, giving you a quick way to practice the rules, question types, and explanations that matter most for Nclexpn.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. INR 1.1
2. Platelets 190,000/mm³
3. Hemoglobin 12.9 g/dL
4. aPTT 110 seconds with bleeding at the IV site (correct answer)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is aPTT 110 seconds with bleeding, indicating excessive anticoagulation from heparin. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by prioritizing reporting to stop infusion and reverse effects. The distractors are less critical as platelets 190,000/mm³, hemoglobin 12.9 g/dL, and INR 1.1 are normal, a misconception that all coagulation labs require action without clinical correlation. The clinical decision-making process includes monitoring aPTT against therapeutic range, assessing for bleeding, and escalating for protamine. A transferable strategy is to trend coagulation studies during anticoagulant therapy. Understanding lab findings like prolonged aPTT is essential in reducing client risk by preventing hemorrhagic complications in thrombosis treatment.

Question 2

1. INR 5.6 with new gum bleeding (correct answer)
2. INR 2.4 with no bleeding
3. Platelets 210,000/mm³
4. Hemoglobin 13.2 g/dL

Explanation: This question tests reduction of risk potential through monitoring anticoagulation therapy and recognizing critical lab values. The INR of 5.6 is critically elevated (nearly double the therapeutic goal of 2.0-3.0) and combined with new bleeding symptoms indicates supratherapeutic anticoagulation requiring immediate intervention. The correct answer (A) reflects appropriate clinical judgment within LPN/VN scope by recognizing that an INR >5 with active bleeding requires immediate RN notification for potential warfarin dose adjustment or reversal. The other options (B: therapeutic INR without bleeding, C: normal platelets, D: normal hemoglobin) represent stable values that don't require immediate intervention, though option B's INR of 2.4 is therapeutic and appropriate for atrial fibrillation. The clinical decision-making process involves recognizing that INR >5 with bleeding symptoms indicates high risk for serious hemorrhage. A transferable strategy is to remember that INR >5 or any INR with new bleeding requires immediate action. Understanding coagulation studies is crucial for preventing life-threatening bleeding complications in anticoagulated patients.

Question 3

1. Potassium 4.0 mEq/L
2. WBC 7,800/mm³
3. Platelets 320,000/mm³
4. Hemoglobin 6.9 g/dL with dizziness (correct answer)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is hemoglobin 6.9 g/dL with dizziness, indicating severe anemia requiring transfusion or further evaluation. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by prioritizing reporting for hemodynamic instability. The distractors are incorrect as WBC 7,800/mm³, platelets 320,000/mm³, and potassium 4.0 mEq/L are normal, a common misconception that fatigue alone does not warrant urgent action without lab confirmation. The clinical decision-making process involves assessing orthostatic symptoms, trending CBC, and escalating for blood products. A transferable strategy is to correlate hemoglobin with clinical signs of tissue hypoxia. Understanding lab findings like low hemoglobin is essential in reducing client risk by preventing syncope or organ damage from anemia.

Question 4

1. Encourage oral fluids and reassess in 2 hours
2. Prepare to perform straight catheterization per protocol/provider order and notify the RN (correct answer)
3. Administer PRN opioid pain medication only
4. Apply a heating pad over the suprapubic area

Explanation: This question tests reduction of risk potential through using bladder scanning to diagnose post-operative urinary retention. The bladder scan showing 650 mL indicates significant urinary retention (>600 mL) requiring catheterization to prevent bladder damage and relieve discomfort. The correct answer (B) reflects appropriate clinical judgment within LPN/VN scope by recognizing that bladder volumes >600 mL require catheterization per protocol while notifying the RN of this post-operative complication. The other options are inappropriate: A (oral fluids won't help empty a distended bladder), C (pain medication alone won't address retention), and D (heat won't resolve mechanical retention). The clinical decision-making process involves recognizing that post-operative urinary retention >600 mL requires mechanical drainage. A transferable strategy is to use bladder scanning to objectively assess retention and guide intervention decisions. Understanding bladder scan interpretation prevents complications like bladder overdistension and post-operative urinary tract infections.

Question 5

1. Respirations 10/min with magnesium level 7.8 mg/dL (correct answer)
2. Blood pressure 148/92 mm Hg
3. Urine output 40 mL/hr
4. Mild flushing and warmth

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key finding is respirations 10/min with magnesium level 7.8 mg/dL, indicating magnesium toxicity causing respiratory depression. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by recognizing the need for antidote like calcium gluconate. The distractors are less critical as BP 148/92 mm Hg, urine output 40 mL/hr, and flushing are expected or mild, a misconception that all preeclampsia treatments are safe without monitoring. The clinical decision-making process involves assessing reflexes and vitals, correlating with levels, and preparing for discontinuation. A transferable strategy is to monitor magnesium levels and symptoms for toxicity in obstetric care. Understanding lab findings like elevated magnesium is crucial in reducing client risk by preventing respiratory arrest in preeclampsia.

Question 6

1. Chloride 100 mEq/L
2. Potassium 3.6 mEq/L
3. Glucose 96 mg/dL
4. Sodium 118 mEq/L with change in level of consciousness (correct answer)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is sodium 118 mEq/L with altered consciousness, indicating severe hyponatremia risking seizures or coma. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by prioritizing reporting for controlled correction. The distractors are less urgent as potassium 3.6 mEq/L, glucose 96 mg/dL, and chloride 100 mEq/L are normal, a misconception that confusion in alcohol use is always intoxication without electrolyte check. The clinical decision-making process involves linking sodium to neurological symptoms, notifying for hypertonic saline. A transferable strategy is to assess sodium in clients with altered mental status and risk factors. Understanding lab findings like low sodium is crucial in reducing client risk by preventing cerebral edema.

Question 7

1. INR 5.2 with new gum bleeding (correct answer)
2. Hemoglobin 13.6 g/dL
3. Platelets 210,000/mm³
4. Sodium 139 mEq/L

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is an INR of 5.2, which is supratherapeutic and indicates an increased risk of bleeding, especially with new gum bleeding symptoms. The correct answer, reporting INR 5.2 with gum bleeding, reflects appropriate clinical judgment within the LPN/VN scope by prioritizing immediate notification to prevent hemorrhage. The distractors are less optimal because hemoglobin 13.6 g/dL, platelets 210,000/mm³, and sodium 139 mEq/L are within normal ranges and do not indicate acute risk, a common misconception being that all lab values require reporting regardless of context. The clinical decision-making process involves assessing the INR against the therapeutic goal, correlating it with bleeding symptoms, and escalating to the RN for potential antidote administration. A transferable strategy is to always compare lab results to reference ranges and clinical symptoms when interpreting coagulation studies. Understanding lab findings like elevated INR is crucial in reducing client risk by enabling timely interventions to prevent life-threatening bleeding.

Question 8

1. Incisional pain rated 6/10
2. Hemoglobin 7.1 g/dL with hypotension and dizziness (correct answer)
3. Temperature 99.1°F (37.3°C)
4. Urine output 40 mL/hr

Explanation: This question tests reduction of risk potential through monitoring post-operative bleeding using hemoglobin levels and clinical signs. The hemoglobin of 7.1 g/dL represents a significant drop from pre-operative levels (11.8 g/dL) and combined with hypotension and orthostatic symptoms indicates active bleeding requiring immediate intervention. The correct answer (B) reflects appropriate clinical judgment within LPN/VN scope by recognizing that hemoglobin <8 g/dL with hemodynamic instability requires immediate RN notification for potential blood transfusion. The other options (A: expected post-operative pain, C: low-grade temperature common post-op, D: adequate urine output) represent normal post-operative findings that don't indicate hemorrhage. The clinical decision-making process involves recognizing that a hemoglobin drop >3 g/dL with hypotension indicates significant blood loss. A transferable strategy is to monitor hemoglobin trends post-operatively and correlate with vital signs to detect bleeding. Understanding post-operative hemoglobin monitoring is essential for early detection and treatment of surgical hemorrhage.

Question 9

1. Vancomycin trough 24 mcg/mL with new tinnitus (correct answer)
2. WBC 12,000/mm³
3. Temperature 100.4°F (38°C)
4. Sodium 136 mEq/L

Explanation: This question tests reduction of risk potential through monitoring vancomycin levels to prevent ototoxicity and nephrotoxicity. The vancomycin trough of 24 mcg/mL exceeds the therapeutic range (10-20 mcg/mL) and the new tinnitus indicates ototoxicity requiring immediate intervention. The correct answer (A) reflects appropriate clinical judgment within LPN/VN scope by recognizing that supratherapeutic vancomycin levels with ototoxic symptoms require immediate RN notification for dose adjustment or discontinuation. The other options (B: slightly elevated WBC expected with infection, C: low-grade fever expected with pneumonia, D: normal sodium) represent expected findings that don't indicate drug toxicity. The clinical decision-making process involves recognizing that tinnitus is an early sign of vancomycin-induced ototoxicity that can progress to permanent hearing loss. A transferable strategy is to monitor vancomycin troughs before the fourth dose and correlate levels >20 mcg/mL with toxicity symptoms. Understanding therapeutic drug monitoring prevents irreversible complications from antimicrobial therapy.

Question 10

1. Chloride 101 mEq/L
2. Potassium 2.9 mEq/L with palpitations (correct answer)
3. Magnesium 1.9 mg/dL
4. Sodium 139 mEq/L

Explanation: This question tests reduction of risk potential through monitoring electrolytes in patients on diuretic therapy. The potassium level of 2.9 mEq/L is critically low (normal 3.5-5.0 mEq/L) and combined with palpitations indicates cardiac effects of hypokalemia requiring immediate intervention. The correct answer (B) reflects appropriate clinical judgment within LPN/VN scope by recognizing that hypokalemia with cardiac symptoms in a heart failure patient requires immediate RN notification for potassium replacement. The other options (A: normal chloride, C: normal magnesium, D: normal sodium) represent stable electrolyte values that don't pose immediate cardiac risk. The clinical decision-making process involves recognizing that hypokalemia increases digoxin toxicity risk and can trigger fatal dysrhythmias in heart failure patients. A transferable strategy is to monitor potassium closely in patients on loop diuretics and correlate levels <3.0 mEq/L with cardiac symptoms. Understanding electrolyte monitoring with diuretic therapy prevents life-threatening dysrhythmias.

Question 11

1. PaCO2 62 mm Hg with pH 7.28 and increasing drowsiness (correct answer)
2. PaO2 58 mm Hg on 2 L/min nasal cannula
3. Bicarbonate 26 mEq/L
4. Oxygen saturation 92% earlier in the shift

Explanation: This question tests reduction of risk potential through interpreting arterial blood gases to identify respiratory failure. The pH of 7.28 with PaCO2 of 62 mm Hg indicates acute respiratory acidosis, and the increasing drowsiness suggests CO2 narcosis requiring immediate intervention. The correct answer (A) reflects appropriate clinical judgment within LPN/VN scope by recognizing that respiratory acidosis with altered mental status indicates ventilatory failure requiring immediate RN notification for potential BiPAP or intubation. While option B (hypoxemia) is also concerning, the CO2 retention with mental status changes represents more immediate life-threatening ventilatory failure; options C and D show compensated values. The clinical decision-making process prioritizes CO2 retention with neurological symptoms as indicating impending respiratory arrest. A transferable strategy is to recognize that PaCO2 >50 mm Hg with pH <7.35 and mental status changes indicates acute ventilatory failure. Understanding ABG interpretation in COPD patients prevents respiratory arrest through early intervention.

Question 12

1. Sodium 137 mEq/L
2. Lithium level 1.8 mEq/L with nausea and tremor (correct answer)
3. Glucose 96 mg/dL
4. Calcium 9.4 mg/dL

Explanation: This question tests reduction of risk potential through monitoring lithium levels and recognizing drug interactions. The lithium level of 1.8 mEq/L is toxic (therapeutic range 0.6-1.2 mEq/L) and the symptoms of nausea, diarrhea, and tremors confirm lithium toxicity likely precipitated by the thiazide diuretic. The correct answer (B) reflects appropriate clinical judgment within LPN/VN scope by recognizing that lithium toxicity requires immediate RN notification for dose adjustment or discontinuation. The other options (A: normal sodium, C: normal glucose, D: normal calcium) represent stable values unrelated to the presenting toxicity. The clinical decision-making process involves recognizing that thiazide diuretics reduce lithium clearance, causing toxicity even at previously stable doses. A transferable strategy is to monitor lithium levels within 5-7 days of starting any diuretic and recognize early toxicity symptoms. Understanding drug interaction effects on lithium levels prevents progression to severe neurotoxicity.

Question 13

1. Creatinine 5.1 mg/dL
2. Potassium 6.4 mEq/L with peaked T waves (correct answer)
3. Sodium 138 mEq/L
4. BUN 44 mg/dL

Explanation: This question tests reduction of risk potential through recognizing life-threatening electrolyte imbalances and their cardiac manifestations. The potassium level of 6.4 mEq/L is critically elevated (normal 3.5-5.0 mEq/L) and the presence of peaked T waves on telemetry confirms cardiac effects requiring immediate intervention. The correct answer (B) reflects appropriate clinical judgment within LPN/VN scope by recognizing that hyperkalemia with ECG changes is a medical emergency requiring immediate RN notification for urgent treatment. The other options (A: elevated creatinine expected in CKD, C: normal sodium, D: elevated BUN expected in CKD) represent chronic kidney disease findings that don't require immediate intervention compared to the cardiac emergency. The clinical decision-making process prioritizes cardiac manifestations of hyperkalemia as most life-threatening. A transferable strategy is to remember that potassium >6.0 mEq/L or any hyperkalemia with ECG changes requires immediate action to prevent cardiac arrest. Understanding electrolyte monitoring in renal disease is essential for preventing fatal dysrhythmias.

Question 14

1. Sepsis (e.g., hypotension, increasing heart rate, confusion) (correct answer)
2. Hypoglycemia (e.g., tremors, diaphoresis)
3. Pulmonary embolism (e.g., sudden chest pain, hemoptysis)
4. Hyperthyroidism (e.g., heat intolerance, exophthalmos)

Explanation: This question tests reduction of risk potential through interpreting urinalysis results to identify urinary tract infection and monitor for complications. The positive nitrites, positive leukocyte esterase, and elevated WBCs confirm bacterial UTI, and the fever of 101.8°F with flank pain suggests pyelonephritis with risk for sepsis progression. The correct answer (A) reflects appropriate clinical judgment within LPN/VN scope by recognizing that UTI with systemic symptoms requires monitoring for sepsis signs (hypotension, tachycardia, altered mental status). The other options are unrelated to UTI complications: B (hypoglycemia unrelated to infection), C (pulmonary embolism not a UTI complication), and D (hyperthyroidism unrelated to acute infection). The clinical decision-making process involves recognizing that pyelonephritis can progress to urosepsis requiring early detection. A transferable strategy is to monitor vital signs and mental status in patients with positive urinalysis and systemic symptoms. Understanding urinalysis interpretation helps identify patients at risk for sepsis from urinary sources.

Question 15

1. Potassium 2.9 mEq/L (correct answer)
2. Sodium 136 mEq/L
3. BUN 18 mg/dL
4. Calcium 9.1 mg/dL

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is potassium 2.9 mEq/L, signifying hypokalemia that can lead to muscle weakness and cardiac dysrhythmias. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by identifying the need for prompt reporting and potential supplementation. The distractors are incorrect because sodium 136 mEq/L, BUN 18 mg/dL, and calcium 9.1 mg/dL are normal, a common misconception that diuretic use only affects fluid balance without electrolyte monitoring. The clinical decision-making process includes assessing for symptoms like cramps, correlating with diuretic therapy, and notifying for replacement orders. A transferable strategy is to trend electrolytes in clients on loop diuretics for early imbalance detection. Understanding lab findings like low potassium is vital in reducing client risk by preventing complications in heart failure management.

Question 16

1. Potassium 5.9 mEq/L (correct answer)
2. Creatinine 2.0 mg/dL
3. Sodium 138 mEq/L
4. Calcium 9.3 mg/dL

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is potassium 5.9 mEq/L, indicating hyperkalemia exacerbated by ACE inhibitor use, with symptoms like weakness. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by prioritizing reporting to avoid cardiac issues. The distractors are less urgent as creatinine 2.0 mg/dL indicates renal impairment but not immediate threat, and sodium 138 mEq/L and calcium 9.3 mg/dL are normal, a misconception that all changes in renal labs are equally critical. The clinical decision-making process includes assessing for drug-induced imbalances, correlating with symptoms, and notifying for dose adjustments. A transferable strategy is to monitor electrolytes in clients on renin-angiotensin system inhibitors. Understanding lab findings like elevated potassium is vital in reducing client risk by preventing arrhythmias in hypertension management.

Question 17

1. Chloride 103 mEq/L
2. Creatinine 2.1 mg/dL
3. Blood urea nitrogen (BUN) 34 mg/dL
4. Potassium 6.4 mEq/L with peaked T waves on telemetry (correct answer)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is potassium 6.4 mEq/L with peaked T waves, indicating hyperkalemia that can cause cardiac arrhythmias. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by identifying the urgent need for intervention to stabilize cardiac rhythm. The distractors are less critical as creatinine 2.1 mg/dL and BUN 34 mg/dL suggest chronic kidney issues without immediate threat, and chloride 103 mEq/L is normal, a misconception being that all elevated renal values require equal urgency. The clinical decision-making process involves linking electrolyte imbalances to ECG changes and symptoms like weakness, prioritizing notification for treatments like kayexalate or dialysis. A transferable strategy is to associate hyperkalemia with ECG abnormalities and renal function when interpreting metabolic panels. Understanding lab findings like elevated potassium is vital in reducing client risk by averting cardiac arrest in vulnerable populations.

Question 18

1. ANC 420/mm³ with fever (correct answer)
2. Hemoglobin 10.8 g/dL
3. Platelets 165,000/mm³
4. Sodium 135 mEq/L

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key finding is ANC 420/mm³ with fever, indicating neutropenia and high infection risk post-chemotherapy. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by identifying the need for isolation and antibiotics. The distractors are less urgent as hemoglobin 10.8 g/dL, platelets 165,000/mm³, and sodium 135 mEq/L are mildly abnormal without symptoms, a misconception that all CBC changes in chemo patients are equivalent. The clinical decision-making process includes calculating ANC, linking to fever, and notifying for sepsis precautions. A transferable strategy is to compute ANC for infection risk assessment in immunocompromised clients. Understanding lab findings like low ANC is crucial in reducing client risk by preventing septic shock in oncology care.

Question 19

1. Elevated troponin with ST-segment elevation on ECG (correct answer)
2. Blood pressure 142/86 mm Hg
3. Respiratory rate 18/min
4. Temperature 98.4°F (36.9°C)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key findings are elevated troponin 0.18 ng/mL with ST-segment elevation on ECG, indicating acute myocardial infarction requiring reperfusion. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by identifying the urgency for intervention like PCI. The distractors are less critical as BP 142/86 mm Hg, RR 18/min, and temperature 98.4°F are stable, a misconception that chest pain without vital sign changes is non-urgent. The clinical decision-making process includes correlating biomarkers with ECG changes, preparing for cath lab. A transferable strategy is to integrate troponin and ECG for ACS diagnosis. Understanding diagnostic findings like elevated troponin is essential in reducing client risk by enabling timely treatment of heart attacks.

Question 20

1. Calcium 9.0 mg/dL
2. Sodium 137 mEq/L
3. Glucose 104 mg/dL
4. Lithium level 1.8 mEq/L with tremors and nausea (correct answer)

Explanation: This question tests reduction of risk potential through lab and diagnostic monitoring. The key lab value is lithium level 1.8 mEq/L with tremors and nausea, indicating toxicity possibly from diuretic interaction. The correct answer reflects appropriate clinical judgment within the LPN/VN scope by prioritizing reporting for dose adjustment or discontinuation. The distractors are incorrect as sodium 137 mEq/L, glucose 104 mg/dL, and calcium 9.0 mg/dL are normal, a common misconception that symptoms are unrelated to drug interactions without levels. The clinical decision-making process involves assessing for toxicity signs, correlating with recent changes, and escalating care. A transferable strategy is to monitor lithium levels with new medications affecting renal clearance. Understanding lab findings like elevated lithium is vital in reducing client risk by preventing severe neurotoxicity in psychiatric care.